Extravasation of docetaxel;Extravasation von Docetaxel

JDDG - Journal of the German Society of Dermatology

Volumn 10, Issue 9, 2012, Pages 662-663

  Cifuentes, Liliana ^a   Ring, Johannes ^a   Brockow, Knut ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BICALUTAMIDE; BUSERELIN ACETATE; DOCETAXEL; LEUPRORELIN; PREDNISOLONE;

ADVANCED CANCER; AGED; ANDROGEN DEPRIVATION THERAPY; ANTIBIOTIC THERAPY; CANCER CHEMOTHERAPY; CASE REPORT; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; INJECTION SITE EXTRAVASATION; LETTER; MALE; PROSTATE CANCER; TRANSURETHRAL RESECTION;

EID: 84865705360     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2012.07973_suppl.x     Document Type: Letter

References (4)

1. Raley J, Geisler JP, Buekers TE, Sorosky JI. Docetaxel extravasation causing significant delayed tissue injury. Gynecol Oncol 2000; 78: 259-60. (Pubitemid 30650365)
2. Berghammer P, Pohnl R, Baur M, Dittrich C. Docetaxel extravasation. Support Care Cancer 2001; 9: 131-4. (Pubitemid 32246461)
3. Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, Rosso R, Pronzato P. Hyaluronidase as an antidote to extravasation of vinca alkaloids: clinical results. J Cancer Res Clin Oncol 1994; 120: 505-6. (Pubitemid 24205130)
4. Nogler-Semenitz E, Mader I, Furst-Weger P, Terkola R, Wassertheurer S, Giovanoli P, Mader RM. [Extravasation of cytotoxic agents]. Wien Klin Wochenschr 2004; 116: 289-95 (Pubitemid 38843135)